The AIBN building officially opens.
AIBN’s first PhD student, Dr Akshat Tanksale graduates
QLD SAFI established, bringing together universities & the aviation industry to research & evaluate regional manufacture of biofuel,
Nanopatch needle-free vaccination technology was spun out into Vaxxas Pty Ltd.
Collaboration with Lanzatech began, with AIBN playing a key role in establishing the company’s commercial-scale gas fermentation capabilities
Creation of a molecular roadmap for the reprogramming process when adult cells are converted into artificial stem cells.
Antibody manufacture for the world-first human clinical trials to treat the Hendra virus
Fibres from Australian native spinifex grass used to improve the properties of latex, in collaboration with Dugalunji Aboriginal Corporation.
Startup company, Scaled Biolabs established to make microfluidic platforms to enable 1000s of cell experiments to run simultaneously.
A new blood test developed using gold nanoparticles to monitor individual cancer cells circulating in the body
Hoover the beagle helped researchers run an Australian-first comparative cancer veterinary trial for nanomedicines
Antibody drug KB312 targeting difficult-to-treat immune system disorders progressed to clinical trials
A world record set for the conversion of solar energy to electricity using tiny nanoparticles called ‘quantum dots’
Development of a new vaccine for COVID-19 began, using UQ’s Molecular Clamp technology, leading to a clinical trial
The ‘immuno-storm chip’ to diagnose cytokine storms in immunotherapy & COVID-19 patients was developed
Antimicrobial surface coating tested by astronauts aboard the International Space Station
Venom gel made from snakes speeds up blood clotting, preventing uncontrolled bleeding in patients
Drug candidate to target debilitating and chronic pain spun-out to Cassowary Pharma
Pioneered a magnetic absorption method to remove PFAS “forever chemicals” from contaminated water
Indigenous spinout company
Gene therapies for Hereditary Spastic Paraplegia Type 56 were tested using organoids as a pilot for treating rare diseases
A plastic was developed that breaks down in seawater, and made using 3D-printing
3D printing method developed to make hybrid soft robots – liquid metal robotics, used for medical devices
Sanofi acquired UQ’s Molecular Clamp technology – the largest deal of a company commercialising intellectual property (IP) from an Australian university.
A new world record set for efficiency of lead-free perovskite solar cells
Creation of a rapid sensor that can detect pregnancy complications from a blood test as early as 11 weeks
First patient trials began in Brisbane for a new therapy to target and treat ovarian cancer. Professor John Hooper and teams have developed the drug over the last 20 years through early-stage development, preclinical studies and now first in-human trials.
Demonstration that brain cells use fatty acids as fuel, not only glucose